Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Pre-Emption Case: ChiefJustice Will Sit This One Out
The U.S. Supreme Court has agreed to review the holding in Brueswitz v. Wyeth, but Chief Justice John Roberts Jr. will not take part. Justice Roberts also was not involved in the decision to hear the case, which asks whether children who claim they are injured by vaccines may take their cases to state court with claims of design defects after losing in the Vaccine Court. A panel of the U.S. Court of Appeals for the Third Circuit last year held in Brueswitz that an injured child's right to bring such suits was pre-empted by the1986 National Childhood Vaccine Injury Act. Justice Roberts' reason for recusal is undoubtedly related to his ownership of stock in Pfizer Inc., which took over Wyeth last year.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.
With trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.